Imagene AI For Profit

Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: Tel Aviv, Tel Aviv, Israel
Founded Date: 1905-07-12
Last Funding Date: 2022-05-02
Total Funding: 21500000
Technology: AI-driven
Employee Number: Tel Aviv, Tel Aviv, Israel
Estimated Revenue: Israel"
Investors Number: 4
Industry: Deep Diagnostics